APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Terbinafine Hydrochloride Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Terbinafine Hydrochloride Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174040290320 December 2025193 pages

Choose your research edition.

Industry ResearchTerbinafine Hydrochloride Drug Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Terbinafine Hydrochloride Drug Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Terbinafine Hydrochloride Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Terbinafine Hydrochloride Drug Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Terbinafine Hydrochloride Drug Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Terbinafine Hydrochloride Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Terbinafine Hydrochloride Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Terbinafine Hydrochloride Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Terbinafine Hydrochloride Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Terbinafine Hydrochloride Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Terbinafine Hydrochloride Drug include APOTEX, Breckenridge Pharmaceutical, CIPLA LTD, Cussess, Dr. Reddy's Laboratories, Glenmark, Harris Pharmaceutical, InvaGen Pharmaceuticals and Orchid Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Terbinafine Hydrochloride Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Terbinafine Hydrochloride Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Terbinafine Hydrochloride Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Terbinafine Hydrochloride Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Terbinafine Hydrochloride Drug Segment by Company

APOTEX

Breckenridge Pharmaceutical

CIPLA LTD

Cussess

Dr. Reddy's Laboratories

Glenmark

Harris Pharmaceutical

InvaGen Pharmaceuticals

Orchid Healthcare

TARO

GSK

Hubei Hengan Fulin Pharm

Jilin Wantong Group

Novartis

TEVA

Xiuzheng Pharmaceutical

Terbinafine Hydrochloride Drug Segment by Type

Topical

Oral

Terbinafine Hydrochloride Drug Segment by Application

Fingernail Infection

Toenail Infection

Others

Terbinafine Hydrochloride Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Terbinafine Hydrochloride Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Terbinafine Hydrochloride Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Terbinafine Hydrochloride Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Terbinafine Hydrochloride Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Terbinafine Hydrochloride Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Terbinafine Hydrochloride Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Terbinafine Hydrochloride Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Terbinafine Hydrochloride Drug Industry Trends Table 2. Terbinafine Hydrochloride Drug Industry Drivers Table 3. Terbinafine Hydrochloride Drug Industry Opportunities and Challenges Table 4. Terbinafine Hydrochloride Drug Industry Restraints Table 5. Global Terbinafine Hydrochloride Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Terbinafine Hydrochloride Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Terbinafine Hydrochloride Drug Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Terbinafine Hydrochloride Drug Sales Market Share by Manufacturers Table 9. Global Terbinafine Hydrochloride Drug Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Terbinafine Hydrochloride Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Terbinafine Hydrochloride Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Terbinafine Hydrochloride Drug Manufacturers, Product Type & Application Table 13. Global Terbinafine Hydrochloride Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Terbinafine Hydrochloride Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Topical Table 17. Major Manufacturers of Oral Table 18. Global Terbinafine Hydrochloride Drug Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 19. Global Terbinafine Hydrochloride Drug Sales by Type (2021-2026) & (W Units) Table 20. Global Terbinafine Hydrochloride Drug Sales by Type (2027-2032) & (W Units) Table 21. Global Terbinafine Hydrochloride Drug Sales Market Share by Type (2021-2026) Table 22. Global Terbinafine Hydrochloride Drug Sales Market Share by Type (2027-2032) Table 23. Global Terbinafine Hydrochloride Drug Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 24. Global Terbinafine Hydrochloride Drug Revenue by Type (2021-2026) & (W Units) Table 25. Global Terbinafine Hydrochloride Drug Revenue by Type (2027-2032) & (W Units) Table 26. Global Terbinafine Hydrochloride Drug Revenue Market Share by Type (2021-2026) Table 27. Global Terbinafine Hydrochloride Drug Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Fingernail Infection Table 29. Major Manufacturers of Toenail Infection Table 30. Major Manufacturers of Others Table 31. Global Terbinafine Hydrochloride Drug Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 32. Global Terbinafine Hydrochloride Drug Sales by Application (2021-2026) & (W Units) Table 33. Global Terbinafine Hydrochloride Drug Sales by Application (2027-2032) & (W Units) Table 34. Global Terbinafine Hydrochloride Drug Sales Market Share by Application (2021-2026) Table 35. Global Terbinafine Hydrochloride Drug Sales Market Share by Application (2027-2032) Table 36. Global Terbinafine Hydrochloride Drug Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 37. Global Terbinafine Hydrochloride Drug Revenue by Application (2021-2026) & (W Units) Table 38. Global Terbinafine Hydrochloride Drug Revenue by Application (2027-2032) & (W Units) Table 39. Global Terbinafine Hydrochloride Drug Revenue Market Share by Application (2021-2026) Table 40. Global Terbinafine Hydrochloride Drug Revenue Market Share by Application (2027-2032) Table 41. Global Terbinafine Hydrochloride Drug Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 42. Global Terbinafine Hydrochloride Drug Sales by Region (2021-2026) & (W Units) Table 43. Global Terbinafine Hydrochloride Drug Sales Market Share by Region (2021-2026) Table 44. Global Terbinafine Hydrochloride Drug Sales Forecasted by Region (2027-2032) & (W Units) Table 45. Global Terbinafine Hydrochloride Drug Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Terbinafine Hydrochloride Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 47. North America Terbinafine Hydrochloride Drug Sales by Country (2021-2026) & (W Units) Table 48. North America Terbinafine Hydrochloride Drug Sales by Country (2027-2032) & (W Units) Table 49. Europe Terbinafine Hydrochloride Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 50. Europe Terbinafine Hydrochloride Drug Sales by Country (2021-2026) & (W Units) Table 51. Europe Terbinafine Hydrochloride Drug Sales by Country (2027-2032) & (W Units) Table 52. Asia Pacific Terbinafine Hydrochloride Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 53. Asia Pacific Terbinafine Hydrochloride Drug Sales by Country (2021-2026) & (W Units) Table 54. Asia Pacific Terbinafine Hydrochloride Drug Sales by Country (2027-2032) & (W Units) Table 55. South America, Middle East and Africa Terbinafine Hydrochloride Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 56. South America, Middle East and Africa Terbinafine Hydrochloride Drug Sales by Country (2021-2026) & (W Units) Table 57. South America, Middle East and Africa Terbinafine Hydrochloride Drug Sales by Country (2027-2032) & (W Units) Table 58. Global Terbinafine Hydrochloride Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Terbinafine Hydrochloride Drug Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Terbinafine Hydrochloride Drug Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Terbinafine Hydrochloride Drug Revenue Market Share by Region (2021-2026) Table 62. Global Terbinafine Hydrochloride Drug Revenue Market Share by Region (2027-2032) Table 63. APOTEX Company Information Table 64. APOTEX Business Overview Table 65. APOTEX Terbinafine Hydrochloride Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. APOTEX Terbinafine Hydrochloride Drug Product Portfolio Table 67. APOTEX Recent Development Table 68. Breckenridge Pharmaceutical Company Information Table 69. Breckenridge Pharmaceutical Business Overview Table 70. Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Product Portfolio Table 72. Breckenridge Pharmaceutical Recent Development Table 73. CIPLA LTD Company Information Table 74. CIPLA LTD Business Overview Table 75. CIPLA LTD Terbinafine Hydrochloride Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. CIPLA LTD Terbinafine Hydrochloride Drug Product Portfolio Table 77. CIPLA LTD Recent Development Table 78. Cussess Company Information Table 79. Cussess Business Overview Table 80. Cussess Terbinafine Hydrochloride Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Cussess Terbinafine Hydrochloride Drug Product Portfolio Table 82. Cussess Recent Development Table 83. Dr. Reddy's Laboratories Company Information Table 84. Dr. Reddy's Laboratories Business Overview Table 85. Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Product Portfolio Table 87. Dr. Reddy's Laboratories Recent Development Table 88. Glenmark Company Information Table 89. Glenmark Business Overview Table 90. Glenmark Terbinafine Hydrochloride Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Glenmark Terbinafine Hydrochloride Drug Product Portfolio Table 92. Glenmark Recent Development Table 93. Harris Pharmaceutical Company Information Table 94. Harris Pharmaceutical Business Overview Table 95. Harris Pharmaceutical Terbinafine Hydrochloride Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Harris Pharmaceutical Terbinafine Hydrochloride Drug Product Portfolio Table 97. Harris Pharmaceutical Recent Development Table 98. InvaGen Pharmaceuticals Company Information Table 99. InvaGen Pharmaceuticals Business Overview Table 100. InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Product Portfolio Table 102. InvaGen Pharmaceuticals Recent Development Table 103. Orchid Healthcare Company Information Table 104. Orchid Healthcare Business Overview Table 105. Orchid Healthcare Terbinafine Hydrochloride Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Orchid Healthcare Terbinafine Hydrochloride Drug Product Portfolio Table 107. Orchid Healthcare Recent Development Table 108. TARO Company Information Table 109. TARO Business Overview Table 110. TARO Terbinafine Hydrochloride Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. TARO Terbinafine Hydrochloride Drug Product Portfolio Table 112. TARO Recent Development Table 113. GSK Company Information Table 114. GSK Business Overview Table 115. GSK Terbinafine Hydrochloride Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. GSK Terbinafine Hydrochloride Drug Product Portfolio Table 117. GSK Recent Development Table 118. Hubei Hengan Fulin Pharm Company Information Table 119. Hubei Hengan Fulin Pharm Business Overview Table 120. Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Product Portfolio Table 122. Hubei Hengan Fulin Pharm Recent Development Table 123. Jilin Wantong Group Company Information Table 124. Jilin Wantong Group Business Overview Table 125. Jilin Wantong Group Terbinafine Hydrochloride Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Jilin Wantong Group Terbinafine Hydrochloride Drug Product Portfolio Table 127. Jilin Wantong Group Recent Development Table 128. Novartis Company Information Table 129. Novartis Business Overview Table 130. Novartis Terbinafine Hydrochloride Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Novartis Terbinafine Hydrochloride Drug Product Portfolio Table 132. Novartis Recent Development Table 133. TEVA Company Information Table 134. TEVA Business Overview Table 135. TEVA Terbinafine Hydrochloride Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. TEVA Terbinafine Hydrochloride Drug Product Portfolio Table 137. TEVA Recent Development Table 138. Xiuzheng Pharmaceutical Company Information Table 139. Xiuzheng Pharmaceutical Business Overview Table 140. Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Product Portfolio Table 142. Xiuzheng Pharmaceutical Recent Development Table 143. Key Raw Materials Table 144. Raw Materials Key Suppliers Table 145. Terbinafine Hydrochloride Drug Distributors List Table 146. Terbinafine Hydrochloride Drug Customers List Table 147. Research Programs/Design for This Report Table 148. Authors List of This Report Table 149. Secondary Sources Table 150. Primary Sources List of Figures Figure 1. Terbinafine Hydrochloride Drug Product Image Figure 2. Global Terbinafine Hydrochloride Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Terbinafine Hydrochloride Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Terbinafine Hydrochloride Drug Sales (2021-2032) & (W Units) Figure 5. Global Terbinafine Hydrochloride Drug Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Terbinafine Hydrochloride Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Topical Image Figure 9. Oral Image Figure 10. Global Terbinafine Hydrochloride Drug Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 11. Global Terbinafine Hydrochloride Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Terbinafine Hydrochloride Drug Sales Market Share by Type (2021-2032) Figure 13. Global Terbinafine Hydrochloride Drug Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 14. Global Terbinafine Hydrochloride Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Terbinafine Hydrochloride Drug Revenue Market Share by Type (2021-2032) Figure 16. Fingernail Infection Image Figure 17. Toenail Infection Image Figure 18. Others Image Figure 19. Global Terbinafine Hydrochloride Drug Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 20. Global Terbinafine Hydrochloride Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Terbinafine Hydrochloride Drug Sales Market Share by Application (2021-2032) Figure 22. Global Terbinafine Hydrochloride Drug Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 23. Global Terbinafine Hydrochloride Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Terbinafine Hydrochloride Drug Revenue Market Share by Application (2021-2032) Figure 25. North America Terbinafine Hydrochloride Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 26. North America Terbinafine Hydrochloride Drug Sales Market Share by Country (2021-2032) Figure 27. U.S. Terbinafine Hydrochloride Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 28. Canada Terbinafine Hydrochloride Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 29. Mexico Terbinafine Hydrochloride Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 30. Europe Terbinafine Hydrochloride Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 31. Europe Terbinafine Hydrochloride Drug Sales Market Share by Country (2021-2032) Figure 32. Germany Terbinafine Hydrochloride Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 33. France Terbinafine Hydrochloride Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 34. U.K. Terbinafine Hydrochloride Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 35. Italy Terbinafine Hydrochloride Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 36. Netherlands Terbinafine Hydrochloride Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 37. Asia Pacific Terbinafine Hydrochloride Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 38. Asia Pacific Terbinafine Hydrochloride Drug Sales Market Share by Country (2021-2032) Figure 39. China Terbinafine Hydrochloride Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 40. Japan Terbinafine Hydrochloride Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 41. South Korea Terbinafine Hydrochloride Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 42. Southeast Asia Terbinafine Hydrochloride Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 43. India Terbinafine Hydrochloride Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 44. Australia Terbinafine Hydrochloride Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 45. South America, Middle East and Africa Terbinafine Hydrochloride Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 46. South America, Middle East and Africa Terbinafine Hydrochloride Drug Sales Market Share by Country (2021-2032) Figure 47. Brazil Terbinafine Hydrochloride Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 48. South Africa Terbinafine Hydrochloride Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 49. Saudi Arabia Terbinafine Hydrochloride Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 50. Turkey Terbinafine Hydrochloride Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 51. Argentina Terbinafine Hydrochloride Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 52. UAE Terbinafine Hydrochloride Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 53. Egypt Terbinafine Hydrochloride Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Chile Terbinafine Hydrochloride Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Global Terbinafine Hydrochloride Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Terbinafine Hydrochloride Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Terbinafine Hydrochloride Drug Revenue (2021-2032) & (US$ Million) Figure 58. North America Terbinafine Hydrochloride Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Terbinafine Hydrochloride Drug Revenue (2021-2032) & (US$ Million) Figure 60. Europe Terbinafine Hydrochloride Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Terbinafine Hydrochloride Drug Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Terbinafine Hydrochloride Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Terbinafine Hydrochloride Drug Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Terbinafine Hydrochloride Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Terbinafine Hydrochloride Drug Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Terbinafine Hydrochloride Drug Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Topical
  • Oral
Applications
  • Fingernail Infection
  • Toenail Infection
  • Others
Companies covered
  • APOTEX
  • Breckenridge Pharmaceutical
  • CIPLA LTD
  • Cussess
  • Dr. Reddy's Laboratories
  • Glenmark
  • Harris Pharmaceutical
  • InvaGen Pharmaceuticals
  • Orchid Healthcare
  • TARO
  • GSK
  • Hubei Hengan Fulin Pharm
  • Jilin Wantong Group
  • Novartis
  • TEVA
  • Xiuzheng Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Terbinafine Hydrochloride Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Terbinafine Hydrochloride Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Terbinafine Hydrochloride Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Terbinafine Hydrochloride Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Terbinafine Hydrochloride Drug Market Dynamics
  1. 2.1 Terbinafine Hydrochloride Drug Industry Trends
  2. 2.2 Terbinafine Hydrochloride Drug Industry Drivers
  3. 2.3 Terbinafine Hydrochloride Drug Industry Opportunities and Challenges
  4. 2.4 Terbinafine Hydrochloride Drug Industry Restraints
3 Terbinafine Hydrochloride Drug Market by Manufacturers
  1. 3.1 Global Terbinafine Hydrochloride Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Terbinafine Hydrochloride Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Terbinafine Hydrochloride Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Terbinafine Hydrochloride Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Terbinafine Hydrochloride Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Terbinafine Hydrochloride Drug Manufacturers, Product Type & Application
  7. 3.7 Global Terbinafine Hydrochloride Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Terbinafine Hydrochloride Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Terbinafine Hydrochloride Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Terbinafine Hydrochloride Drug Tier 1, Tier 2, and Tier 3
4 Terbinafine Hydrochloride Drug Market by Type
  1. 4.1 Terbinafine Hydrochloride Drug Type Introduction
  2. 4.1.1 Topical
  3. 4.1.2 Oral
  4. 4.2 Global Terbinafine Hydrochloride Drug Sales by Type
  5. 4.2.1 Global Terbinafine Hydrochloride Drug Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Terbinafine Hydrochloride Drug Sales by Type (2021-2032)
  7. 4.2.3 Global Terbinafine Hydrochloride Drug Sales Market Share by Type (2021-2032)
  8. 4.3 Global Terbinafine Hydrochloride Drug Revenue by Type
  9. 4.3.1 Global Terbinafine Hydrochloride Drug Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Terbinafine Hydrochloride Drug Revenue by Type (2021-2032)
  11. 4.3.3 Global Terbinafine Hydrochloride Drug Revenue Market Share by Type (2021-2032)
5 Terbinafine Hydrochloride Drug Market by Application
  1. 5.1 Terbinafine Hydrochloride Drug Application Introduction
  2. 5.1.1 Fingernail Infection
  3. 5.1.2 Toenail Infection
  4. 5.1.3 Others
  5. 5.2 Global Terbinafine Hydrochloride Drug Sales by Application
  6. 5.2.1 Global Terbinafine Hydrochloride Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Terbinafine Hydrochloride Drug Sales by Application (2021-2032)
  8. 5.2.3 Global Terbinafine Hydrochloride Drug Sales Market Share by Application (2021-2032)
  9. 5.3 Global Terbinafine Hydrochloride Drug Revenue by Application
  10. 5.3.1 Global Terbinafine Hydrochloride Drug Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Terbinafine Hydrochloride Drug Revenue by Application (2021-2032)
  12. 5.3.3 Global Terbinafine Hydrochloride Drug Revenue Market Share by Application (2021-2032)
6 Global Terbinafine Hydrochloride Drug Sales by Region
  1. 6.1 Global Terbinafine Hydrochloride Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Terbinafine Hydrochloride Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Terbinafine Hydrochloride Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Terbinafine Hydrochloride Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Terbinafine Hydrochloride Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Terbinafine Hydrochloride Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Terbinafine Hydrochloride Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Terbinafine Hydrochloride Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Terbinafine Hydrochloride Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Terbinafine Hydrochloride Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Terbinafine Hydrochloride Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Terbinafine Hydrochloride Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Terbinafine Hydrochloride Drug Revenue by Region
  1. 7.1 Global Terbinafine Hydrochloride Drug Revenue by Region
  2. 7.1.1 Global Terbinafine Hydrochloride Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Terbinafine Hydrochloride Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Terbinafine Hydrochloride Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Terbinafine Hydrochloride Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Terbinafine Hydrochloride Drug Revenue (2021-2032)
  8. 7.2.2 North America Terbinafine Hydrochloride Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Terbinafine Hydrochloride Drug Revenue (2021-2032)
  11. 7.3.2 Europe Terbinafine Hydrochloride Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Terbinafine Hydrochloride Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Terbinafine Hydrochloride Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Terbinafine Hydrochloride Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Terbinafine Hydrochloride Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 APOTEX
  2. 8.1.1 APOTEX Company Information
  3. 8.1.2 APOTEX Business Overview
  4. 8.1.3 APOTEX Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 APOTEX Terbinafine Hydrochloride Drug Product Portfolio
  6. 8.1.5 APOTEX Recent Developments
  7. 8.2 Breckenridge Pharmaceutical
  8. 8.2.1 Breckenridge Pharmaceutical Company Information
  9. 8.2.2 Breckenridge Pharmaceutical Business Overview
  10. 8.2.3 Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Product Portfolio
  12. 8.2.5 Breckenridge Pharmaceutical Recent Developments
  13. 8.3 CIPLA LTD
  14. 8.3.1 CIPLA LTD Company Information
  15. 8.3.2 CIPLA LTD Business Overview
  16. 8.3.3 CIPLA LTD Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 CIPLA LTD Terbinafine Hydrochloride Drug Product Portfolio
  18. 8.3.5 CIPLA LTD Recent Developments
  19. 8.4 Cussess
  20. 8.4.1 Cussess Company Information
  21. 8.4.2 Cussess Business Overview
  22. 8.4.3 Cussess Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Cussess Terbinafine Hydrochloride Drug Product Portfolio
  24. 8.4.5 Cussess Recent Developments
  25. 8.5 Dr. Reddy's Laboratories
  26. 8.5.1 Dr. Reddy's Laboratories Company Information
  27. 8.5.2 Dr. Reddy's Laboratories Business Overview
  28. 8.5.3 Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Product Portfolio
  30. 8.5.5 Dr. Reddy's Laboratories Recent Developments
  31. 8.6 Glenmark
  32. 8.6.1 Glenmark Company Information
  33. 8.6.2 Glenmark Business Overview
  34. 8.6.3 Glenmark Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Glenmark Terbinafine Hydrochloride Drug Product Portfolio
  36. 8.6.5 Glenmark Recent Developments
  37. 8.7 Harris Pharmaceutical
  38. 8.7.1 Harris Pharmaceutical Company Information
  39. 8.7.2 Harris Pharmaceutical Business Overview
  40. 8.7.3 Harris Pharmaceutical Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Harris Pharmaceutical Terbinafine Hydrochloride Drug Product Portfolio
  42. 8.7.5 Harris Pharmaceutical Recent Developments
  43. 8.8 InvaGen Pharmaceuticals
  44. 8.8.1 InvaGen Pharmaceuticals Company Information
  45. 8.8.2 InvaGen Pharmaceuticals Business Overview
  46. 8.8.3 InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Product Portfolio
  48. 8.8.5 InvaGen Pharmaceuticals Recent Developments
  49. 8.9 Orchid Healthcare
  50. 8.9.1 Orchid Healthcare Company Information
  51. 8.9.2 Orchid Healthcare Business Overview
  52. 8.9.3 Orchid Healthcare Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Orchid Healthcare Terbinafine Hydrochloride Drug Product Portfolio
  54. 8.9.5 Orchid Healthcare Recent Developments
  55. 8.10 TARO
  56. 8.10.1 TARO Company Information
  57. 8.10.2 TARO Business Overview
  58. 8.10.3 TARO Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 TARO Terbinafine Hydrochloride Drug Product Portfolio
  60. 8.10.5 TARO Recent Developments
  61. 8.11 GSK
  62. 8.11.1 GSK Company Information
  63. 8.11.2 GSK Business Overview
  64. 8.11.3 GSK Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 GSK Terbinafine Hydrochloride Drug Product Portfolio
  66. 8.11.5 GSK Recent Developments
  67. 8.12 Hubei Hengan Fulin Pharm
  68. 8.12.1 Hubei Hengan Fulin Pharm Company Information
  69. 8.12.2 Hubei Hengan Fulin Pharm Business Overview
  70. 8.12.3 Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Product Portfolio
  72. 8.12.5 Hubei Hengan Fulin Pharm Recent Developments
  73. 8.13 Jilin Wantong Group
  74. 8.13.1 Jilin Wantong Group Company Information
  75. 8.13.2 Jilin Wantong Group Business Overview
  76. 8.13.3 Jilin Wantong Group Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Jilin Wantong Group Terbinafine Hydrochloride Drug Product Portfolio
  78. 8.13.5 Jilin Wantong Group Recent Developments
  79. 8.14 Novartis
  80. 8.14.1 Novartis Company Information
  81. 8.14.2 Novartis Business Overview
  82. 8.14.3 Novartis Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Novartis Terbinafine Hydrochloride Drug Product Portfolio
  84. 8.14.5 Novartis Recent Developments
  85. 8.15 TEVA
  86. 8.15.1 TEVA Company Information
  87. 8.15.2 TEVA Business Overview
  88. 8.15.3 TEVA Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 TEVA Terbinafine Hydrochloride Drug Product Portfolio
  90. 8.15.5 TEVA Recent Developments
  91. 8.16 Xiuzheng Pharmaceutical
  92. 8.16.1 Xiuzheng Pharmaceutical Company Information
  93. 8.16.2 Xiuzheng Pharmaceutical Business Overview
  94. 8.16.3 Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Product Portfolio
  96. 8.16.5 Xiuzheng Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Terbinafine Hydrochloride Drug Value Chain Analysis
  2. 9.1.1 Terbinafine Hydrochloride Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Terbinafine Hydrochloride Drug Production Mode & Process
  6. 9.2 Terbinafine Hydrochloride Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Terbinafine Hydrochloride Drug Distributors
  9. 9.2.3 Terbinafine Hydrochloride Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst